在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

inhA Antibody

Rare Species
  • 中文名稱:
    inhA兔多克隆抗體
  • 貨號:
    CSB-PA363781HA01MVZ
  • 規(guī)格:
    ¥440
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品名稱:
    Rabbit anti-Mycobacterium tuberculosis inhA Polyclonal antibody
  • Uniprot No.:
  • 基因名:
    inhA
  • 別名:
    inhA antibody; Rv1484 antibody; MTCY277.05 antibody; Enoyl-[acyl-carrier-protein] reductase [NADH] antibody; ENR antibody; Enoyl-ACP reductase antibody; EC 1.3.1.9 antibody; FAS-II enoyl-ACP reductase antibody; NADH-dependent 2-trans-enoyl-ACP reductase antibody
  • 宿主:
    Rabbit
  • 反應(yīng)種屬:
    Mycobacterium tuberculosis
  • 免疫原:
    Recombinant Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase [NADH] protein (1-269AA)
  • 免疫原種屬:
    Mycobacterium tuberculosis
  • 標(biāo)記方式:
    Non-conjugated

    本頁面中的產(chǎn)品,inhA Antibody (CSB-PA363781HA01MVZ),的標(biāo)記方式是Non-conjugated。對于inhA Antibody,我們還提供其他標(biāo)記。見下表:

    可提供標(biāo)記
    標(biāo)記方式 貨號 產(chǎn)品名稱 應(yīng)用
    HRP CSB-PA363781HB01MVZ inhA Antibody, HRP conjugated ELISA
    FITC CSB-PA363781HC01MVZ inhA Antibody, FITC conjugated
    Biotin CSB-PA363781HD01MVZ inhA Antibody, Biotin conjugated ELISA
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    >95%, Protein G purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產(chǎn)品提供形式:
    Liquid
  • 應(yīng)用范圍:
    ELISA
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價(jià)

靶點(diǎn)詳情

  • 功能:
    Enoyl-ACP reductase of the type II fatty acid syntase (FAS-II) system, which is involved in the biosynthesis of mycolic acids, a major component of mycobacterial cell walls. Catalyzes the NADH-dependent reduction of the double bond of 2-trans-enoyl-[acyl-carrier protein], an essential step in the fatty acid elongation cycle of the FAS-II pathway. Shows preference for long-chain fatty acyl thioester substrates (>C16), and can also use 2-trans-enoyl-CoAs as alternative substrates. The mycobacterial FAS-II system utilizes the products of the FAS-I system as primers to extend fatty acyl chain lengths up to C56, forming the meromycolate chain that serves as the precursor for final mycolic acids.; Is the primary target of the first-line antitubercular drug isoniazid (INH) and of the second-line drug ethionamide (ETH). Overexpressed inhA confers INH and ETH resistance to M.tuberculosis. The mechanism of isoniazid action against InhA is covalent attachment of the activated form of the drug to the nicotinamide ring of NAD and binding of the INH-NAD adduct to the active site of InhA. Similarly, the ETH-NAD adduct binds InhA.
  • 基因功能參考文獻(xiàn):
    1. Out of the 141 isolates studied, 3 (2.1%) were found carrying mutations in the katG gene that confer resistance to Isoniazid (INH). No mutations were detected in the inhA promoter region gene that confer weak INH resistance or in the rpoB gene that confer Rifampicin resistance. PMID: 29868151
    2. Molecular dynamics (MD) simulation show that EN and N1 remained in the binding pocket similar to the docked pose of EN-InhA and E1-InhA complexes and also suggested that InhA binds to its inhibitor in inhibitor-induced folding manner. Our study concludes that multiple receptor conformers based molecular docking can be an alternative to study the effect of receptor flexibility in ligand binding PMID: 28957755
    3. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum. PMID: 27490275
    4. Structural analysis of InhA provided the crucial points to enhance the NADH binding affinity towards InhA mutants in the presence of direct InhA inhibitors to combat isoniazid drug resistance. PMID: 26658674
    5. InhA gene mutation is associated with isoniazid resistance in Mycobacterium tuberculosis. PMID: 25799046
    6. The specific zone mutations in inhA gene for rifampicin and isoniazid were investigated with molecular methods in isolated unique PMID: 26506671
    7. Rational Modulation of the Induced-Fit Conformational Change for Slow-Onset Inhibition in Mycobacterium tuberculosis InhA. PMID: 26147157
    8. The study reports empirical parameters to differentiate the 'open' and 'closed' conformation of substrate-binding loop by comprehensive ana-lysis of InhA crystal structures. PMID: 24895891
    9. The results reveal that the presence of a mutation in the inhA regulatory region together with a mutation in the inhA coding region can lead to the development of high-level isoniazid resistance and cross-resistance to ethionamide among the MDR-TB strains circulating in Lisbon. PMID: 23539241
    10. No mutation was observed in the inhA promotor region or in the INH sensitive control isolate (H37Rv). PMID: 22358357
    11. We chose to search for new inhibitors of the enoyl-acyl carrier protein reductase InhA, the target of the first-line TB drug isoniazid. Two compounds (CD39 and CD117) were bactericidal against drug-susceptible and drug-resistant M. tuberculosis. PMID: 21628538
    12. inhA promoter mutations are strongly associated with extensively drug-resistant-tuberculosis in South Africa PMID: 21333101
    13. Phosphorylation of InhA inhibits mycolic acid biosynthesis and growth of Mycobacterium tuberculosis. PMID: 21143326
    14. InhA phosphorylation is an important event in regulating cell growth. PMID: 20864541
    15. inhA(S94A) allele confers clinically relevant levels of resistance to isoniazid killing & inhibition of mycolic acid synthesis. decreased binding of INH-NAD inhibitor to InhA establishes InhA as primary target of isoniazid action in M. tuberculosis. PMID: 16906155
    16. catalysis of substrate reduction by InhA results, in part, from correct orientation of the cofactor in the ground state PMID: 17472376
    17. T (-8)C of inhA mutations was found in multidrug resistant Mycobacterium tuberculosis isolates. PMID: 17539290
    18. The structure of two InhA mutants (I21V and S94A), identified in INH-resistant clinical isolates, were solved. PMID: 17588773
    19. inhibited by Anthecotulide from Anthemis auriculata PMID: 18424102

    顯示更多

    收起更多

  • 蛋白家族:
    Short-chain dehydrogenases/reductases (SDR) family, FabI subfamily
  • 數(shù)據(jù)庫鏈接:

    KEGG: mtu:Rv1484

    STRING: 83332.Rv1484



主站蜘蛛池模板: 乌克兰少妇videos高潮| 欧美性猛少妇xxxxx免费| 丁香婷婷综合激情五月色| 亚洲色成人网一二三区| 国产亚洲精品久久久久5区| 狠狠色噜噜狠狠狠888777米奇| 中文无码人妻影音先锋| 国产超碰人人做人人爱ⅴa| 亚洲精品美女久久久久99| 久久综合色_综合色88| 国产精品久久久久久不卡盗摄| 国产午夜精品一区理论片飘花| 午夜视频久久久久一区| 免费无码av片在线观看网址| 国产亚洲精品久久yy50| 国产精品久久国产精品99 gif | 国产亚洲精品一区二三区| 久久久久久久久久久久久9999| 国产另类ts人妖一区二区| 日韩av片无码一区二区三区| 日本一本一区二区免费播放| 日韩人妻一区二区三区蜜桃视频 | 三级做a全过程在线观看| 国产999久久高清免费观看 | 中文字幕欧美亚州视频免费| 精品一区二区三区在线成人| 黑人巨茎大战欧美白妇免费| 亚洲成av人片天堂网九九| 国产三级做爰在线播放| 天天爽夜夜爽夜夜爽精品视频| 久久精品人人做人人爽老司机| 蜜桃mv在线播放免费观看视频| 狠狠综合久久av一区二区| 2020国产欧洲精品网站| 免费大香伊蕉在人线国产卡| 国产偷国产偷亚洲高清日韩| 欧美z0zo人禽交欧美人禽交 | 日本乱码伦午夜福利在线| 亚洲精品无码久久久久久| 亚洲精品夜夜夜妓女网| 日本又黄又爽又色又刺激的视频 |